Skip to main content
Back to feed
HealthReportedMedium
5.0

Ireland HSE delays decision on Mounjaro reimbursement over multibillion-euro cost

Ireland's HSE is weighing whether to reimburse the weight-loss drug Mounjaro, with a decision months away due to its multibillion-euro budget impact. The drug is currently available privately but not publicly funded. This reflects broader fiscal pressure on European health systems from GLP-1 drugs.

The Journalabout 21 hours agoIEengCredibility 20%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.2

Intelligence Tags

#glp-1#mounjaro#hse#pharmaceuticals#health-policy#ireland
Source

Related signals

8 found